Abstracts - faqs.org

Abstracts

Zoology and wildlife conservation

Search abstracts:
Abstracts » Zoology and wildlife conservation

The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis

Article Abstract:

Some Mycobacterium tuberculosis (M. tuberculosis) strains are becoming resistant to the anti-tuberculosis drug isoniazid. The resistant strains' lack of the gene katG encoding the enzymes catalase and peroxidase has been found to cause isoniazid's diminished therapeutic effectiveness. This finding was verified when insertion of katG in the resistant bacteria Mycobacterium smegmatis and Escherichia coli caused them to again be susceptible to isoniazid. Furthermore, removal of katG from M. tuberculosis chromosome was linked to isoniazid resistance in two patient isolates of M. tuberculosis.

Author: Young, Douglas, Zhang, Ying, Heym, Beate, Allen, Bryan, Cole, Stewart
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1992
Health aspects, Genetic aspects, Drug resistance in microorganisms, Microbial drug resistance, Enzymes, Mycobacterium tuberculosis, Peroxidase, Isoniazid

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


NIP domain prevents N-type inactivation in voltage-gated potassium channels

Article Abstract:

It has been established that neither Kv1.4- nor Kv-beta-1.1-ball domains rapidly inactivate hetermultimeric Kv channels containing Kv1.6 subunits, even though these channels have a functional ball receptor and a conserved Kv-beta-1-binding domain. N-type inactivation was restored through deletion or mutation of the N-type inactivation-prevention domain. This research has established a new channel for the gating behaviour of heteromultimeric Kv channels.

Author: Zhang, Ying, Pongs, Olaf, Roeper, Jochen, Sewing, Sabine, Sommer, Tobias, Wanner, Siegmund G.
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1998
Potassium channels

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Receptor-associated Mad homologues synergize as effectors of the TGF-beta response

Article Abstract:

The human Mad homologues hMad-3 and -4 synergize to produce strong ligand-independent transforming growth factor-beta (TGF-beta) responses. They act as dominant-negative inhibitors of the normal TGF-beta response when truncated at the carboxy terminal. The hMad-4 homolgue is identical to DPC-4 and functions as a tumour suppressor. The inactivation of DPC-4 prevents transforming TGF-beta responsiveness and the attenuation of growth.

Author: Derynck, Rik, Zhang, Ying, Feng, Xin-Hua, Wu, Rui-Yun
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1996
Antineoplastic agents, Transforming growth factors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research
Similar abstracts:
  • Abstracts: The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gamma RIII complex
  • Abstracts: Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Persistence of Mycobacterium tuberculosis in macrophages and mice requires glyoxylate shunt enzyme isocitrate lyase
  • Abstracts: The mahogany protein is a receptor involved in suppression of obesity. The missing link with obesity?
  • Abstracts: Nucleotide-dependent angular change in kinesin motor domain bound to tubulin. Prokaryotic origin of the actin cytoskeleton
  • Abstracts: British report real decline in spending on research. Last chance for British Ass? Towards real-time molecular demolition?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.